which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
After publication of the original article (Knudsen et al. 2016) , the following corrections, and addition of citations were requested:
On page 2, Method section: subsection: Patientreported outcome measures:
It is an 8 item test, 7 items rated dichotomously as "yes/no" responses, and one item rated on a 5-point frequency scale. A total score on the MMAS ranges from 0 to 8 points; <6 point indicates low adherence; 6 < 8 points indicates medium adherence; and 8 points reflects high adherence (Morisky et al. 2008 ). MMAS-8 has been translated to several languages, and many psychometric tests of the translated instrument have been performed. The scale has demonstrated good sensitivity but only moderate internal consistency. The scale has also demonstrated convergent validity with electronic measures and is a reliable tool to determine medication adherence (Morisky et al. 2008 (Morisky et al. , 2011 Arnet et al. 2015; KrouselWood et al. 2009 ).
On page 4, Table 2 and on page 5, Fig. 1 , the copyright statement "Use of the ©MMAS is protected by US and International copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 16636 159th
Place SE, Renton WA 98058, dmorisky@gmail.com" must be included as a footnote.
On page 7, References, the following references should be included: 
